Thursday, August 01, 2013 3:12:06 AM
Cytokinetics is eligible to receive over $40 million from Astellas over the next two years which comes in the form of a $16 million upfront non-refundable license fee and over $24 million in reimbursed sponsored research and development cost
http://www.earningsimpact.com/Transcript/82557/CYTK/Q2-2013-Earnings-Call
Recent CYTK News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/10/2024 08:00:19 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/09/2024 08:08:35 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 09:28:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 09:27:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 09:26:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 09:25:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 09:24:18 PM
- Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 10/03/2024 08:00:00 PM
- Cytokinetics to Host Investor & Analyst Day on October 16, 2024 • GlobeNewswire Inc. • 10/02/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 08:48:30 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/01/2024 08:21:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/30/2024 10:56:15 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/30/2024 08:06:57 PM
- Cytokinetics Presents Additional Data From SEQUOIA-HCM at the HFSA Annual Scientific Meeting • GlobeNewswire Inc. • 09/30/2024 01:20:00 PM
- Cytokinetics Presents Additional Data from SEQUOIA-HCM at the HCMS Scientific Sessions • GlobeNewswire Inc. • 09/27/2024 03:00:00 PM
- Cytokinetics Announces Call for Proposals for Its Seventh Annual Communications Grant Program • GlobeNewswire Inc. • 09/24/2024 11:30:00 AM
- Cytokinetics Announces Upcoming Presentations at the HCMS Scientific Sessions and the HFSA Annual Scientific Meeting • GlobeNewswire Inc. • 09/19/2024 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:15:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/17/2024 08:10:40 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:03:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 08:29:54 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/09/2024 08:12:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 08:05:54 PM
- Cytokinetics Announces Data From Phase 1 Study of CK-4021586 • GlobeNewswire Inc. • 09/09/2024 11:30:00 AM
- Cytokinetics Announces Two Presentations at the 2024 American College of Clinical Pharmacology Annual Meeting • GlobeNewswire Inc. • 09/05/2024 08:00:00 PM
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM